| Page 65 | Kisaco Research

Top insiders reveal behind-the-scenes insights on bold mergers, creative alliances, and disruptive MSO strategies. Gain quantifiable metrics from recent deals, practical tips on integration, and proven approaches for building scalable, sustainable value in a consolidating market. 

Growth & Expansion
Future Trends & Market Intelligence
Legal & IP
Funding & M&A
Moderator

Author:

Allison Beller

Partner
Prelude Growth Partners

Allison Beller is a partner at Prelude Growth Partners, a New York-based, female-founded consumer growth fund. Prior to joining Prelude, Allison was a Managing Director at Goldman Sachs & Co in the Private Equity group within the Asset Management Division, where she worked for over 18 years. Her investing experience covered the Consumer and Services landscape. Allison began her career at Credit Suisse First Boston in the Financial Sponsors group. Allison received a Bachelors of Science in Finance from The Wharton School of the University of Pennsylvania. 

Allison Beller

Partner
Prelude Growth Partners

Allison Beller is a partner at Prelude Growth Partners, a New York-based, female-founded consumer growth fund. Prior to joining Prelude, Allison was a Managing Director at Goldman Sachs & Co in the Private Equity group within the Asset Management Division, where she worked for over 18 years. Her investing experience covered the Consumer and Services landscape. Allison began her career at Credit Suisse First Boston in the Financial Sponsors group. Allison received a Bachelors of Science in Finance from The Wharton School of the University of Pennsylvania. 

Author:

David Marks

Partner
Holland & Knight

David Marks enjoys closing fast-paced, high-pressure deals by aligning economic interests on both sides of the transaction. His practice focuses on buy-side and sell-side private equity M&A, and he has extensive experience in healthcare and other industries. In recent years, Mr. Marks has played a key role in numerous middle-market healthcare transactions involving dental, dermatology, ophthalmology, optometry and optical, chiropractic and physical therapy, women's health, gastroenterology and other specialties.

Private equity clients, investors and sellers value his counsel in recapitalizations, add-on acquisitions and roll-ups. Additionally, Mr. Marks represents private equity firms, investors and privately held companies in sales of portfolio companies and investments involving PE acquirers. Clients benefit from his ability to bring deals to successful conclusions despite the challenges often posed by the complex financing structures and deadlines of private equity transactions.

Previously, Mr. Marks gained valuable experience as an associate in New York where he advised private equity firms, distressed businesses and major financial institutions in the design and implementation of sweeping operational and financial restructurings and M&A in some of the largest Chapter 11 cases in recent history.

David Marks

Partner
Holland & Knight

David Marks enjoys closing fast-paced, high-pressure deals by aligning economic interests on both sides of the transaction. His practice focuses on buy-side and sell-side private equity M&A, and he has extensive experience in healthcare and other industries. In recent years, Mr. Marks has played a key role in numerous middle-market healthcare transactions involving dental, dermatology, ophthalmology, optometry and optical, chiropractic and physical therapy, women's health, gastroenterology and other specialties.

Private equity clients, investors and sellers value his counsel in recapitalizations, add-on acquisitions and roll-ups. Additionally, Mr. Marks represents private equity firms, investors and privately held companies in sales of portfolio companies and investments involving PE acquirers. Clients benefit from his ability to bring deals to successful conclusions despite the challenges often posed by the complex financing structures and deadlines of private equity transactions.

Previously, Mr. Marks gained valuable experience as an associate in New York where he advised private equity firms, distressed businesses and major financial institutions in the design and implementation of sweeping operational and financial restructurings and M&A in some of the largest Chapter 11 cases in recent history.

Author:

Ben Hernandez

CEO & Managing Director
Skytale Group

Ben Hernandez

CEO & Managing Director
Skytale Group

Author:

John Wheeler

Founder & CEO
Alpha Aesthetics Partners

John Wheeler

Founder & CEO
Alpha Aesthetics Partners

Author:

Sarah Brooks Gabriel

CEO
Beverly Hills Rejuvenation Center

Sarah Brooks Gabriel

CEO
Beverly Hills Rejuvenation Center

Master the art of scaling with soul and strategy. Pinpoint how leading operators use demographic and economic data to target high-value geographies, secure smart real estate deals that reinforce brand identity, and navigate multi-state requirements to maximize returns. 

Growth & Expansion
Future Trends & Market Intelligence
Marketing & Brand Positioning
Legal & IP

Author:

Lynn Heublein

Co-Founder & CEO
SkinSpirit

Lynn Heublein

Co-Founder & CEO
SkinSpirit

Author:

Ryan Rao

Chief Development Officer
VIO Med Spa

Ryan Rao

Chief Development Officer
VIO Med Spa

Curate value-driven journeys that keep customers engaged, boost visit frequency, and inspire loyalty. Blend seamless member experiences, personalized perks, and feedback loops to strengthen your brand community and amplify advocacy, while building predictable long-term revenue.  

Client Experience & Retention
Growth & Expansion

Author:

Sophia Dickerson

Premium Relationship Manager
Phorest

Sophia Dickerson

Premium Relationship Manager
Phorest

Author:

Phil Murray

CEO
milk + honey

Phil Murray

CEO
milk + honey

Author:

Nicci Levy

CEO & Founder
Alchemy43

Nicci Levy

CEO & Founder
Alchemy43

Author:

Gabby Garritano

Founder & CEO
JECT

Gabby Garritano

Founder & CEO
JECT

From buzzword to business decision, explore the latest clinical evidence, regulatory realities, and ROI frameworks in regenerative aesthetics. Separating promises from proven outcomes, uncover if, when, and how exosomes fit your 2026 growth strategy. 

Treatment Innovation

Author:

Joel Marshall

CEO
Dp Derm

Joel Marshall

CEO
Dp Derm

Author:

Dr. Shino Bay Aguilera

Board-Certified Dermatologist & Owner
Shino Bay Cosmetic Dermatology and Laser Institute

Dr. Shino Bay Aguilera

Board-Certified Dermatologist & Owner
Shino Bay Cosmetic Dermatology and Laser Institute

Your systems should scale as fast as you do. Discover how inventory automation, AI forecasting, and smart procurement can cut waste, tighten control, and unlock hidden margin. Build a tech-powered operation that boosts profits and puts you ahead of the competition.  

Operational Excellence
Growth & Expansion

Author:

Niklas Hess

Founder
Medvelle

Niklas Hess

Founder
Medvelle

Author:

Emily Fernandez

Co-Founder & VP, Operations
Evolve Med Spa

Emily Fernandez

Co-Founder & VP, Operations
Evolve Med Spa

Author:

Lisa Rossmann

Chief Concept Officer
Hand & Stone

Lisa Rossmann

Chief Concept Officer
Hand & Stone

Author:

Alyssa Rapp

CEO
Empower Aesthetics

Alyssa Rapp

CEO
Empower Aesthetics

In an increasingly competitive field, harness AI-powered analysis, benchmarking intelligence, and precision pricing models for sustainable success. Convert insights into synchronised, margin-boosting playbooks that your teams can execute at scale across every location.  

Operational Excellence
Growth & Expansion
Moderator

Author:

Alex Lirtsman

Founder & CEO
CorralData

Alex Lirtsman

Founder & CEO
CorralData

Author:

Melissa Rogne

Founder & President
Chapter Aesthetic Studio

Melissa Rogne

Founder & President
Chapter Aesthetic Studio

Author:

Ariel Clay

Chief Operating Officer
Woodhouse Spas

Ariel Clay

Chief Operating Officer
Woodhouse Spas

Author:

Chris Andrews

Chief Information & Digital Officer
European Wax Center

Chris Andrews

Chief Information & Digital Officer
European Wax Center

Author:

Lisa Paley

CEO
Revision Skincare

Lisa Paley

CEO
Revision Skincare

Author:

Manish Goomar

Chief Technology Officer
Options Medical Weight Loss

Manish Goomar

Chief Technology Officer
Options Medical Weight Loss
 

Brian Doyle

Executive Vice President of Growth
Rectangle Health

Brian Doyle

Executive Vice President of Growth
Rectangle Health

Brian Doyle

Executive Vice President of Growth
Rectangle Health

From advanced actives to AI diagnostics and regenerative breakthroughs, the aesthetic landscape is evolving faster than ever - and so are client demands. Uncover the trends, technologies, and treatment shifts redefining performance, safety, and scale in 2026.

 

Future Trends & Market Intelligence
Growth & Expansion
Treatment Innovation
 

Linh Sherrod

Director of Revenue Cycle
BAM Dental Group

Linh Sherrod

Director of Revenue Cycle
BAM Dental Group

Linh Sherrod

Director of Revenue Cycle
BAM Dental Group

Culture isn’t a bonus - it’s a business asset. Attract, engage, and retain top providers by building environments where loyalty, performance, and purpose thrive. Boost retention, reduce churn, and create a team that grows with your brand.

Operational Excellence